SCHEMBL13009346

SCHEMBL13009346

CC1(C)c2ccccc2-c2ccc(-c3cccc(-c4c5ccc(N6c7ccccc7Sc7ccccc76)cc5c(-c5cccc(-c6ccc7c(c6)C(C)(C)c6ccccc6-7)c5)c5ccc(N6c7ccccc7Sc7ccccc76)cc45)c3)cc21

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.31
PDK2 Q15119 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13427209 1.00 PGR (0.31) PGRPDK2HDAC6
SCHEMBL13009188 0.98 PDK2 (0.31) PGRPDK2
SCHEMBL13009398 0.96 HDAC6 (0.33) PGRHDAC6
SCHEMBL13427133 0.96 HDAC6 (0.33) PGRHDAC6
SCHEMBL13009400 0.95 HDAC6 (0.31) PGRPDK2HDAC6
SCHEMBL13009145 0.95 HDAC6 (0.31) PGRPDK2HDAC6
SCHEMBL13427167 0.94 BCHE (0.31)
SCHEMBL13427207 0.94 BCHE (0.31)
SCHEMBL13427203 0.94 PDK2 (0.32) PGRPDK2HDAC6
SCHEMBL13008885 0.94 BCHE (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PGR 2458/4885PDK2 3608/4885HDAC6 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.